We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Duchesnay Flagged for Omitting Risks of Morning Sickness Drug
Duchesnay Flagged for Omitting Risks of Morning Sickness Drug
Shortly after Duchesnay received FDA approval for its morning sickness drug Diclegis, the agency says the Canadian drugmaker sent a letter to customers touting the drug’s benefits but none of its risks.